ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $15,000 | 0.0% | 343 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $15,000 | -87.9% | 343 | -88.7% | 0.00% | -84.6% |
Q1 2021 | $124,000 | -33.0% | 3,036 | -25.6% | 0.01% | -27.8% |
Q4 2020 | $185,000 | +28.5% | 4,082 | 0.0% | 0.02% | 0.0% |
Q3 2020 | $144,000 | -6.5% | 4,082 | 0.0% | 0.02% | -14.3% |
Q2 2020 | $154,000 | +32.8% | 4,082 | +1.4% | 0.02% | +23.5% |
Q1 2020 | $116,000 | -75.7% | 4,025 | -56.3% | 0.02% | -57.5% |
Q4 2019 | $478,000 | -5.2% | 9,217 | +0.4% | 0.04% | -14.9% |
Q3 2019 | $504,000 | +23.8% | 9,180 | -8.4% | 0.05% | +67.9% |
Q2 2019 | $407,000 | +34.3% | 10,027 | 0.0% | 0.03% | +21.7% |
Q1 2019 | $303,000 | -10.1% | 10,027 | 0.0% | 0.02% | -14.8% |
Q4 2018 | $337,000 | -20.3% | 10,027 | 0.0% | 0.03% | +200.0% |
Q3 2018 | $423,000 | -1.4% | 10,027 | -25.2% | 0.01% | +12.5% |
Q2 2018 | $429,000 | -35.6% | 13,400 | 0.0% | 0.01% | -38.5% |
Q1 2018 | $666,000 | -7.8% | 13,400 | 0.0% | 0.01% | -7.1% |
Q4 2017 | $722,000 | -7.1% | 13,400 | 0.0% | 0.01% | -6.7% |
Q3 2017 | $777,000 | +17.5% | 13,400 | 0.0% | 0.02% | +15.4% |
Q2 2017 | $661,000 | +13.6% | 13,400 | 0.0% | 0.01% | +18.2% |
Q1 2017 | $582,000 | -11.3% | 13,400 | 0.0% | 0.01% | -21.4% |
Q4 2016 | $656,000 | +2.3% | 13,400 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $641,000 | -10.8% | 13,400 | 0.0% | 0.01% | -12.5% |
Q2 2016 | $719,000 | +20.0% | 13,400 | 0.0% | 0.02% | +23.1% |
Q1 2016 | $599,000 | +6.8% | 13,400 | -8.8% | 0.01% | +8.3% |
Q4 2015 | $561,000 | +24.1% | 14,700 | +3.5% | 0.01% | +20.0% |
Q3 2015 | $452,000 | -3.6% | 14,200 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $469,000 | -55.2% | 14,200 | -44.1% | 0.01% | -54.5% |
Q1 2015 | $1,046,000 | +1.1% | 25,400 | 0.0% | 0.02% | 0.0% |
Q4 2014 | $1,035,000 | -50.9% | 25,400 | -50.0% | 0.02% | -8.3% |
Q3 2014 | $2,108,000 | +79.1% | 50,800 | +100.0% | 0.02% | -7.7% |
Q2 2014 | $1,177,000 | +80.2% | 25,400 | +59.7% | 0.03% | +73.3% |
Q1 2014 | $653,000 | +20.5% | 15,900 | +12.0% | 0.02% | +15.4% |
Q4 2013 | $542,000 | +9.1% | 14,200 | -31.7% | 0.01% | 0.0% |
Q3 2013 | $497,000 | +66.8% | 20,800 | +18.9% | 0.01% | +62.5% |
Q2 2013 | $298,000 | – | 17,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |